Study to compare hemodynamic stability and analgesia in patients recieving Propofol -Fentanyl Vs Propofol -Ketamine combination

Comparative study of Propofol -Ketamine Vs Propofol -Fentanyl combination for hemodynamic stability and analgesia in adult patients undergoing elective short surgical procedures - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062339

Enrollment

Registered

2024-02-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs

Interventions

Intervention1: Profol-Fentanyl: To evaluate hemodynamic stability and analgesia in patients recieving Profol-Fentanyl combination in short surgical procedures of 30-60 minutes duration Control Interve

Eligibility

Inclusion criteria

Inclusion criteria: Patients from 18-60years of age scheduled for elective surgeries of 30-90 mins duration and belonging to ASA Grade I and II

Exclusion criteria

Exclusion criteria: Patients who are hemodynamically unstable History of anaphylaxis or allergy to the study drugs Pregnant females History of head injury or seizure disorders Psychiatric illness or drug abuse BMI more than equal to 30 kg per metre square

Design outcomes

Primary

Measure	Time frame
To compare hemodynamic stability of Propofol-Fentanyl Vs Propofol -Ketamine combination in elective short surgical proceduresTimepoint: To compare hemodynamic stability of Propofol-Fentanyl Vs Propofol -Ketamine combination in elective short surgical procedures of 30-90 minutes duration over a period of 1.5 years	—

Secondary

Measure	Time frame
To compare analgesia in patients recieving Profol-Fentanyl Vs Propofol -Ketamine combination in elective short surgical procedures of duration 30 to 60 minutesTimepoint: Outcome will be assessed at the end of one & half year of study	—

Countries

India

Contacts

Public ContactSarvjeet kaur

Guru Gobind Singh Medical College and Hospital

drsarvjeetk@gmail.com9915680508

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026